Literature DB >> 25455091

Effective CKD care in European countries: challenges and opportunities for health policy.

Aminu K Bello1, Adeera Levin2, Braden J Manns3, John Feehally4, Tilman Drueke5, Labib Faruque6, Brenda R Hemmelgarn3, Charles Kernahan7, Johannes Mann8, Scott Klarenbach6, Giuseppe Remuzzi9, Marcello Tonelli6.   

Abstract

Chronic kidney disease (CKD) is an important global public health problem that is associated with adverse health outcomes and high health care costs. Effective and cost-effective treatments are available for slowing the progression of CKD and preventing its complications, including cardiovascular disease. Although wealthy nations have highly structured schemes in place to support the care of people with kidney failure, less consideration has been given to health systems and policy for the much larger population of people with non-dialysis-dependent CKD. Further, how to integrate such strategies with national and international initiatives for control of other chronic noncommunicable diseases (NCDs) merits attention. We synthesized the various approaches to CKD control across 17 European countries and present our findings according to the key domains suggested by the World Health Organization framework for NCD control. This report identifies opportunities to strengthen CKD-relevant health systems and explores potential mechanisms to capitalize on these opportunities. Across the 17 countries studied, we found a number of common barriers to the care of people with non-dialysis-dependent CKD: limited work force capacity, the nearly complete absence of mechanisms for disease surveillance, lack of a coordinated CKD care strategy, poor integration of CKD care with other NCD control initiatives, and low awareness of the significance of CKD. These common challenges faced by diverse health systems reflect the need for international cooperation to strengthen health systems and policies for CKD care.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease (CKD); Europe; Kidney Health for Life (KH4L); care structures; chronic noncommunicable disease (NCD); health systems; non–dialysis-dependent CKD; organization; policy; public health

Mesh:

Year:  2014        PMID: 25455091     DOI: 10.1053/j.ajkd.2014.07.033

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  32 in total

1.  Prevalence and recognition of chronic kidney disease in Stockholm healthcare.

Authors:  Alessandro Gasparini; Marie Evans; Josef Coresh; Morgan E Grams; Olof Norin; Abdul R Qureshi; Björn Runesson; Peter Barany; Johan Ärnlöv; Tomas Jernberg; Björn Wettermark; Carl G Elinder; Juan-Jesüs Carrero
Journal:  Nephrol Dial Transplant       Date:  2016-10-13       Impact factor: 5.992

2.  Pre-dialysis renal clinic visits and patients' outcomes on peritoneal dialysis.

Authors:  Wen Tang; Xiu-Hong Hu; Lei Zhu; Zhe-Li Niu; Chu-Yan Su; Qing-Feng Han; Tao Wang
Journal:  Int Urol Nephrol       Date:  2016-09-01       Impact factor: 2.370

Review 3.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

Review 4.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

5.  Assessment of Global Kidney Health Care Status.

Authors:  Aminu K Bello; Adeera Levin; Marcello Tonelli; Ikechi G Okpechi; John Feehally; David Harris; Kailash Jindal; Babatunde L Salako; Ahmed Rateb; Mohamed A Osman; Bilal Qarni; Syed Saad; Meaghan Lunney; Natasha Wiebe; Feng Ye; David W Johnson
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272

Review 6.  Phosphodiesterase type 5 inhibitors and kidney disease.

Authors:  Baris Afsar; Alberto Ortiz; Adrian Covic; Abduzhappar Gaipov; Tarik Esen; David Goldsmith; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-08-05       Impact factor: 2.370

7.  Kidney health for everyone everywhere: from prevention to detection and equitable access to care.

Authors:  Philip Kam-Tao Li; Guillermo Garcia-Garcia; Siu-Fai Lui; Sharon Andreoli; Winston Wing-Shing Fung; Anne Hradsky; Latha Kumaraswami; Vassilios Liakopoulos; Ziyoda Rakhimova; Gamal Saadi; Luisa Strani; Ifeoma Ulasi; Kamyar Kalantar-Zadeh
Journal:  J Nephrol       Date:  2020-04       Impact factor: 3.902

8.  Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country's healthcare expenditure and nephrologist workforce?

Authors:  Sophie Liabeuf; Karlijn J Van Stralen; Fergus Caskey; Francesca Tentori; Ronald L Pisoni; Ayesha Sajjad; Kitty J Jager; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2017-10-01       Impact factor: 5.992

Review 9.  Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world.

Authors:  Barnaby Hole; Brenda Hemmelgarn; Edwina Brown; Mark Brown; Mignon I McCulloch; Carlos Zuniga; Sharon P Andreoli; Peter G Blake; Cécile Couchoud; Alfonso M Cueto-Manzano; Gavin Dreyer; Guillermo Garcia Garcia; Kitty J Jager; Marla McKnight; Rachael L Morton; Fliss E M Murtagh; Saraladevi Naicker; Gregorio T Obrador; Jeffrey Perl; Muhibur Rahman; Kamal D Shah; Wim Van Biesen; Rachael C Walker; Karen Yeates; Alexander Zemchenkov; Ming-Hui Zhao; Simon J Davies; Fergus J Caskey
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

10.  Morning Blood Pressure Surge as a Predictor of Development of Chronic Kidney Disease.

Authors:  Osman Turak; Baris Afsar; Dimitrie Siriopol; Firat Ozcan; Kumral Cagli; Cagri Yayla; Fatih Oksuz; Mehmet Ali Mendi; Kazuomi Kario; Adrian Covic; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.